Stockscreener 앱 받기
1.10
1.36%
-0.005
전일 마감가:
$1.105
열려 있는:
$1.1
하루 거래량:
17,911
Relative Volume:
0.47
시가총액:
$12.73M
수익:
$996.00K
순이익/손실:
$-6.09M
주가수익비율:
-2.0755
EPS:
-0.53
순현금흐름:
$-9.76M
1주 성능:
-1.36%
1개월 성능:
-7.63%
6개월 성능:
+5.83%
1년 성능:
-36.26%
1일 변동 폭
$1.0801
$1.11
1주일 범위
$1.055
$1.1195
52주 변동 폭
$0.70
$2.44
Therapeuticsmd Inc Stock (TXMD) Company Profile
명칭
Therapeuticsmd Inc
전화
561-961-1900
주소
951 YAMATO ROAD, SUITE 220, BOCA RATON, FL
TXMD을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TXMD
Therapeuticsmd Inc
|
1.10 | 12.50M | 996.00K | -6.09M | -9.76M | -0.53 |
|
ZTS
Zoetis Inc
|
152.01 | 66.04B | 9.39B | 2.61B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.77 | 45.57B | 29.98B | 958.27M | 5.31B | 0.2964 |
|
HLN
Haleon Plc Adr
|
9.705 | 42.50B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.07 | 18.84B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
308.80 | 13.59B | 2.99B | 1.21B | 1.13B | 25.06 |
Therapeuticsmd Inc Stock (TXMD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2020-08-07 | 다운그레이드 | Jefferies | Hold → Underperform |
| 2020-05-19 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2019-12-02 | 개시 | Guggenheim | Buy |
| 2019-10-17 | 개시 | H.C. Wainwright | Buy |
| 2019-04-30 | 재개 | Noble Capital Markets | Outperform |
| 2018-06-15 | 개시 | JP Morgan | Overweight |
| 2017-09-08 | 개시 | Morgan Stanley | Equal-Weight |
| 2017-07-11 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2017-05-09 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2016-11-22 | 재개 | Jefferies | Buy |
| 2016-11-22 | 개시 | Oppenheimer | Outperform |
| 2016-11-07 | 재개 | Guggenheim | Buy |
| 2016-04-04 | 개시 | Goldman | Buy |
| 2015-12-08 | 재확인 | Jefferies | Buy |
| 2015-12-08 | 재확인 | Stifel | Buy |
| 2015-09-21 | 재확인 | Jefferies | Buy |
| 2015-06-09 | 개시 | Guggenheim | Buy |
| 2014-07-08 | 개시 | FBR Capital | Outperform |
| 2014-04-17 | 재확인 | Noble Financial | Buy |
| 2014-01-28 | 재확인 | Noble Financial | Buy |
모두보기
Therapeuticsmd Inc 주식(TXMD)의 최신 뉴스
Using fundamentals and technicals on TherapeuticsMD Inc.2025 Market Trends & Weekly Watchlist for Hot Stocks - Newser
What’s the recovery path for long term holders of TherapeuticsMD Inc.July 2025 Highlights & Free Low Drawdown Momentum Trade Ideas - Newser
What makes TherapeuticsMD Inc. stock price move sharplyJuly 2025 Institutional & Consistent Profit Alerts - Newser
TherapeuticsMD: Q2 Earnings Snapshot - New Haven Register
Published on: 2025-08-13 05:39:11 - Newser
Will TherapeuticsMD Inc. rebound enough to break evenJuly 2025 Update & AI Driven Price Predictions - Newser
TherapeuticsMD Reports Q2 Profitability, Exceeding 2024 Results - AInvest
TherapeuticsMD Announces Second Quarter 2025 Financial Results - BioSpace
Has TherapeuticsMD Inc. formed a bullish divergence [2025 Winners & Losers]Daily Volume Surge Signals - Newser
Signal strength of TherapeuticsMD Inc. stock in tech scannersHigh Confidence Strategy with Trend Alignment - Newser
TherapeuticsMD Inc. Rebounds From Oversold Zone — Now WhatConsistent Income Focused Trade List Analyzed - beatles.ru
TherapeuticsMD Swings to Profit in Q2 - Nasdaq
TherapeuticsMD Reports Q2 2025 Financial Results - TipRanks
How to interpret RSI for TherapeuticsMD Inc. stockDay Trading Setup and Momentum Analysis - Newser
Using flow based indicators on TherapeuticsMD Inc.Price Spike Prediction for Active Traders - Newser
TherapeuticsMD, Inc. SEC 10-Q Report - TradingView
Can volume confirm reversal in TherapeuticsMD Inc.Swing Watchlist With Tight Stop Placement - Newser
Market reaction to TherapeuticsMD Inc.’s recent newsWeekly Stock Movement Prediction Watchlist - Newser
Regression analysis insights on TherapeuticsMD Inc. performanceStable Swing Setup with Safety Analysis - Newser
Published on: 2025-08-11 03:11:11 - Newser
Is TherapeuticsMD Inc. stock ready for a breakoutLow Drawdown Stock Screener with Analysis - Newser
Published on: 2025-08-11 00:15:37 - Newser
How TherapeuticsMD Inc. stock performs during market volatilityFree Low Risk Equity Screener With Results - Newser
Developing predictive dashboards with TherapeuticsMD Inc. dataBuy List With Technical Entry Triggers - Newser
What recovery options are there for TherapeuticsMD Inc.Free High Growth Low Risk Stock Selection - Newser
What to expect from TherapeuticsMD Inc. in the next 30 daysTrend Confirmation Scanner with Entry Focus - Newser
Does TherapeuticsMD Inc. qualify in momentum factor screeningStable Swing Setup with Safety Analysis - Newser
Is TherapeuticsMD Inc. stock bottoming outShort-Term Price Breakout Signal Analysis - Newser
Therapeuticsmd TXMD 2025Q2 Earnings Preview Upside Potential on New Product Launch - AInvest
Tools to monitor TherapeuticsMD Inc. recovery probabilityROI Focused Watchlist with Trade Confidence - Newser
Why TherapeuticsMD Inc. is moving todayInvestment Position Summary with Timeframe Forecast - Newser
Visual trend scoring systems applied to TherapeuticsMD Inc.Investment Timeline and ROI Summary Report - Newser
TherapeuticsMD (NASDAQ:TXMD) Stock Price Up 0.5% – Should You Buy? - Defense World
TherapeuticsMD Inc. stock trend forecastTechnical Setup Guide for Daily Watchlist - Newser
Will TherapeuticsMD Inc. see short term momentumDaily Breakout List with Smart Filters - Newser
TherapeuticsMD Inc. Company’s Quarterly Earnings Growth: What the Numbers SayTechnical Confirmation System with Signal Alerts - Newser
Traders Watching For Reversal Pattern in TherapeuticsMD Inc.Intraday Trade Ideas - beatles.ru
Therapeuticsmd Inc (TXMD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Therapeuticsmd Inc 주식 (TXMD) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Walker Marlan D | Chief Executive Officer |
Apr 14 '25 |
Buy |
1.00 |
490 |
489 |
73,639 |
| Walker Marlan D | Chief Executive Officer |
Apr 10 '25 |
Buy |
0.86 |
1,167 |
1,000 |
73,149 |
| Walker Marlan D | Chief Executive Officer |
Apr 09 '25 |
Buy |
0.87 |
1,136 |
994 |
71,982 |
| Collins Cooper C. | Director |
Feb 18 '25 |
Option Exercise |
0.00 |
8,500 |
0 |
60,516 |
| Naughton Gail K | Director |
Feb 18 '25 |
Option Exercise |
0.00 |
8,500 |
0 |
8,500 |
| Thompson Tommy G | Director |
Feb 18 '25 |
Option Exercise |
0.00 |
8,500 |
0 |
14,454 |
| Walker Marlan D | Chief Executive Officer |
Feb 18 '25 |
Option Exercise |
0.00 |
8,281 |
0 |
70,846 |
| Collins Cooper C. | Director |
Aug 22 '24 |
Buy |
1.73 |
4,094 |
7,099 |
52,016 |
| Collins Cooper C. | Director |
Aug 21 '24 |
Buy |
1.70 |
1,200 |
2,039 |
47,922 |
3.26%
자본화:
|
볼륨(24시간):